Immunohistochemistry (for GFAP) results revealed significantly decreased the IA value of GFAP expression in diabetic SCI rats following rapamycin treatment relative to diabetes + SCI alone ((P < 0.05; Fig. 5F,G). The gene discussed is GFAP; the disease is diabetes mellitus.